Radiopharmaceutical chemistry with iodine-124: A non-standard radiohalogen for positron emission tomography

Medicinal Chemistry

Volumn 7, Issue 5, 2011, Pages 395-412

  Chacko, Ann Marie ^a   Divgi, Chaitanya R ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Iodine 124; Molecular imaging; Nanoparticles; Positron emission tomography; Proteins; Radiochemistry

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 1,3,4,6 TETRACHLORO 3ALPHA,6ALPHA DIPHENYLGLYCOURACIL; 2,3 DIHYDRO 1H IMIDAZO[1,2 B]PYRAZOLE; 7ALPHA IODO 5ALPHA DIHYDROTESTOSTERONE I 124; ALIPHATIC COMPOUND; ANDROSTANOLONE; IDOXIFENE; IDOXIFENE I 124; IODINE 124; IODOBEADS; IODOGEN; IODOPHENYLALANINE I 124; NANOPARTICLE; TOSYLCHLORAMIDE SODIUM; UNCLASSIFIED DRUG;

DRUG HALF LIFE; DRUG STRUCTURE; DRUG SYNTHESIS; ISOTOPE LABELING; MACROMOLECULE; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; RADIOIODINATION; REVIEW;

ANIMALS; HUMANS; IODINE RADIOISOTOPES; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 80052006490     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340611796799221     Document Type: Review

References (135)

1. Massoud, T. F.; Gambhir, S. S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev., 2003, 17, 545-580. (Pubitemid 36307540)
2. Weissleder, R.; Pittet, M. J. Imaging in the era of molecular oncology. Nature, 2008, 452, 580-589. (Pubitemid 351483372)
3. Holland, J. P.; Williamson, M. J.; Lewis, J. S. Unconventional nuclides for radiopharmaceuticals. Mol. Imaging, 2010, 9, 1-20.
4. Lewis, J. S.; Welch, M. J.; Tang, L. Workshop on the production, application and clinical translation of "non-standard" PET nuclides: a meeting report. Q. J. Nucl. Med. Mol. Imaging, 2008, 52, 101-106. (Pubitemid 351721928)
5. Hoffman, E. J.; Huang, S. C.; Phelps, M. E.; Kuhl, D. E. Quantitation in positron emission computed tomography: 4. Effect of accidental coincidences. J. Comput. Assist. Tomogr., 1981, 5, 391-400. (Pubitemid 11105519)
6. Herzog, H.; Tellmann, L.; Scholten, B.; Coenen, H. H.; Qaim, S. M. PET imaging problems with the non-standard positron emitters Yttrium-86 and Iodine-124. Q. J. Nucl. Med. Mol. Imaging, 2008, 52, 159-165. (Pubitemid 351721936)
7. Pentlow, K. S.; Graham, M. C.; Lambrecht, R. M.; Daghighian, F.; Bacharach, S. L.; Bendriem, B.; Finn, R. D.; Jordan, K.; Kalaigian, H.; Karp, J. S.; Robeson, W. R.; Larson, S. M. Quantitative imaging of iodine-124 with PET. J. Nucl. Med., 1996, 37, 1557-1562. (Pubitemid 26321647)
8. Delacroix, D.; P. Guerre, J.; Leblanc, P.; Hickman, C. Radionuclide and Radiation Protection Data Handbook 2002. Radiat. Prot. Dosim., 2002, 98, 1-168.
9. Johansson, L.; Mattsson, S.; Nosslin, B.; Leide-Svegborn, S. Effective dose from radiopharmaceuticals. Eur. J. Nucl. Med., 1992, 19, 933-938.
10. Rault, E.; Vandenberghe, S.; Van Holen, R.; De Beenhouwer, J.; Staelens, S.; Lemahieu, I. Comparison of image quality of different iodine isotopes (I-123, I-124, and I-131). Cancer. Biother. Radiopharm., 2007, 22, 423-430. (Pubitemid 47067901)
11. Kung, M. P.; Kung, H. F. Mass effect of injected dose in small rodent imaging by SPECT and PET. Nucl. Med. Biol., 2005, 32, 673-678. (Pubitemid 41502971)
12. Koehler, L.; Gagnon, K.; McQuarrie, S.; Wuest, F. Iodine-124: a promising positron emitter for organic PET chemistry. Molecules, 2010, 15, 2686-2718.
13. 2 targets. Appl. Radiat. Isot., 2000, 52, 181-184.
14. Sheh, Y.; Koziorowski, J.; Balatoni, J.; Lom, C.; Dahl, J. R.; Finn, R. D. Low energy cyclotron production and chemical separation of "no carrier added" iodine-124 from a reusable, enriched tellurium-124 dioxide/aluminum oxide solid solution target. Radiochim. Acta., 2000, 88, 169-173.
15. 2-targets. Radiochim. Acta, 2000, 88, 175.
16. 124I. Appl. Radiat. Isot., 2001, 55, 149-156. (Pubitemid 32241029)
17. 124I at a small cyclotron. Appl. Radiat. Isot., 1995, 46, 255-259.
18. 120gI at a small-sized cyclotron. Appl. Radiat. Isot., 2003, 58, 69-78. (Pubitemid 35453949)
19. 124I reaction. Appl. Radiat. Isot., 2007, 65, 407-412. (Pubitemid 46177651)
20. 124I reaction. Appl. Radiat. Isot., 2006, 64, 965-970. (Pubitemid 44119185)
21. Glaser, M.; Mackay, D. B.; Ranicar, A. S. O.; Waters, S. L.; Brady, F.; Luthra, S. K. Improved targetry and production of iodine-124 for PET studies. Radiochim. Acta, 2004, 92, 951-956. (Pubitemid 40065444)
22. 123I-process at a low-energy cyclotron. Appl. Radiat. Isot., 1989, 40, 127-132. (Pubitemid 19025888)
23. 7Be) reactions on medium and heavy mass nuclei induced by 53 MeV d (Be)-breakup neutrons. Radiochim. Acta., 1993, 62, 107-113.
24. Seevers, R. H.; Counsell, R. E. Radioiodination techniques for small organic molecules. Chem. Rev., 1982, 82, 575-590.
25. Stöcklin, G. Bromine-77 and iodine-123 radiopharmaceuticals. Int. J. Appl. Radiat. Isot., 1977, 28, 131-148.
26. Coenen, H. H.; Mertens, J.; Mazière, B. Radioionidation Reactions for Pharmaceuticals: Compendium for Effective Synthesis Strategies. Springer: Dordrecht, The Netherlands, 2006.
27. Downer, J. B.; Jones, L. A.; Engelbach, J. A.; Lich, L. L.; Mao, W.; Carlson, K. E.; Katzenellenbogen, J. A.; Welch, M. J. Comparison of animal models for the evaluation of radiolabeled androgens. Nucl. Med. Biol., 2001, 28, 613-626. (Pubitemid 32772863)
28. Eersels, J. L. H.; Travis, M. J.; Herscheid, J. D. M. Manufacturing I-123-labelled radiopharmaceuticals. Pitfalls and solutions. J. Label. Compd. Radiopharm., 2005, 48, 241-257.
29. 18F]FAZA-first small animal PET results. J. Pharm. Pharm. Sci., 2007, 10, 203-211.
30. 124I: a PET agent for the adrenal. Int. J. Rad. Appl. Instrum. A, 1990, 41, 1223-1224.
31. Zanzonico, P.; O'Donoghue, J.; Chapman, J. D.; Schneider, R.; Cai, S.; Larson, S.; Wen, B.; Chen, Y.; Finn, R.; Ruan, S.; Gerweck, L.; Humm, J.; Ling, C. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning. Eur. J. Nucl. Med. Mol. Imaging, 2004, 31, 117-128. (Pubitemid 38133549)
32. Schneider, R. F.; Engelhardt, E. L.; Stobbe, C. C.; Fenning, M. C.; Chapman, J. D. The synthesis and radiolabelling of novel markers of tissue hypoxia of the iodinated azomycin nucleoside class. J. Label. Compd. Radiopharm., 1997, 39, 541-557. (Pubitemid 27270514)
33. 124I-IAZG PET in the same study cohort. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35, 39-46. (Pubitemid 350234134)
34. Weichert, J. P.; Moser, A. R.; Weber, S. M.; Qi, C.; Longino, M. A. Radioiodinated NM404-a Universal Tumor Imaging Agent? Acad. Radiol., 2005, 12, S58-S59.
35. Weichert, J. P.; Van Dort, M. E.; Groziak, M. P.; Counsell, R. E. Radioiodination via isotope exchange in pivalic acid. Int. J. Rad. Appl. Instrum. A, 1986, 37, 907-913. (Pubitemid 17192409)
36. Moerlein, S. M.; Hwang, D. R.; Welch, M. J. No-carrier-added radiobromination via cuprous chloride-assisted nucleophilic aromatic bromodeiodination. Int. J. Rad. Appl. Instrum. A, 1988, 39, 369-372.
37. Moerlein, S. M. Regiospecific aromatic radioiodination via nocarrier-added copper (I) chloride-assisted iododebromination. Radiochim. Acta, 1990, 50, 55-61.
38. Tarle, M.; Padovan, R.; Spaventi, S. Radioiodination of Iodinated Estradiol-17-Diphosphates. J. Label. Compd. Radiopharm., 1978, 15, 7-21. (Pubitemid 9057185)
39. Schirbel, A.; Coenen, H. H. Comparison of non-isotopic exchange methods for n. c.a. labelling of 2-iodophenyl-metyrapone. Nucl. Med. Biol., 1995, 22, 1075-1079.
40. 124I-MIBG. J. Nucl. Med., 2007, 48, 827-836. (Pubitemid 47604985)
41. Stahlschmidt, A.; Machulla, H. J.; Reischl, G.; Knaus, E. E.; Wiebe, L. I. Radioiodination of 1-(2-deoxy-β-D-ribofuranosyl)-2, 4-difluoro-5- iodobenzene (dRFIB), a putative thymidine mimic nucleoside for cell proliferation studies. Appl. Radiat. Isot., 2008, 66, 1221-1228. (Pubitemid 352033709)
42. 123, 124I]beta-CIT, plasma analysis and pharmacokinetic studies with SPECT and PET. Nucl. Med. Biol., 1995, 22, 977-984.
43. Cascini, G. L.; Ciarmiello, A.; Labate, A.; Tamburrini, S.; Quattrone, A. Unexpected detection of melanoma brain metastasis by PET with iodine-124 betaCIT. Clin. Nucl. Med., 2009, 34, 698-699.
44. Fraker, P. J.; Speck, J. C., Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro-3α, 6α-diphrenylglycoluril. Biochem. Biophys. Res. Commun., 1978, 80, 849-857. (Pubitemid 8305904)
45. 123I]IBZM: A potential dopamine D-2 receptor imaging agent. J. Label. Compd. Radiopharm., 1989, 27, 691-700. (Pubitemid 19133402)
46. Bailey, G. The Lactoperoxidase Method for Radiolabeling Protein. In: The Protein Protocols Handbook. Walker JM, Ed.; Humana Press: New York, 2002, 967-968.
47. Eckelman, W. C.; Adams, H. R.; Paik, C. H. Electrophilic iodination of aromatic rings. Int. J. Nucl. Med. Biol., 1984, 11, 163-166. (Pubitemid 14095342)
48. 14C]palmitic acid in murine tissues. J. Nucl. Med., 1984, 25, 1335-1342. (Pubitemid 15222878)
49. Machulla, H. J.; Marsmann, M.; Dutschka, K. Radiopharmaceuticals.1. Synthesis of Radioiodinated Phenylfatty Acids for Studying Myocardial- Metabolism. J. Radioanal. Chem., 1980, 56, 253-261.
50. Kim, S. W.; Park, J. H.; Yang, S. D.; Hur, M. G.; Choi, C. W.; Yu, K. R. Synthesis and in vitro/vivo Evaluation of Iodine-123/124 Labelled Hypericin Derivatives. Bull. Korean Chem. Soc., 2008, 29, 2023-2025.
51. Karioti, A.; Bilia, A. R. Hypericins as potential leads for new therapeutics. Int. J. Mol. Sci., 2010, 11, 562-594.
52. 124I]Iodo- 2'-deoxyuridine for functional PET imaging of cell proliferation. Nucl. Med. Biol., 1998, 25, 359-365. (Pubitemid 28219099)
53. Tjuvajev, J. G.; Finn, R.; Watanabe, K.; Joshi, R.; Oku, T.; Kennedy, J.; Beattie, B.; Koutcher, J.; Larson, S.; Blasberg, R. G. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res., 1996, 56, 4087-4095. (Pubitemid 26304995)
54. 124I]iododeoxyuridine. Cancer Res., 2000, 60, 624-635. (Pubitemid 30094560)
55. 124I]FIAU in cat and man. J. Nucl. Med., 2001, 42, 467-475. (Pubitemid 32207399)
56. Goodman, M. M.; Kung, M. P.; Kabalka, G. W.; Kung, H. F.; Switzer, R. Synthesis and characterization of radioiodinated N-(3-iodopropen-1-yl)-2 beta-carbomethoxy-3 beta-(4-chlorophenyl) tropanes: potential dopamine reuptake site imaging agents. J. Med. Chem., 1994, 37, 1535-1542. (Pubitemid 24174092)
57. 131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas. Appl. Radiat. Isot., 2008, 66, 513-522. (Pubitemid 351288532)
58. 124I]iodouracil: a new potential PET imaging agent for HSV1-tk expression. J. Med. Chem., 2007, 50, 6032-6038.
59. Carnochan, P.; Trivedi, M.; Young, H.; Eccles, S.; Potter, G.; Haynes, B.; Ott, R. Biodistribution and kinetics of radiolabelled pyrrolidino-4-iodo- tamoxifen: prospects for pharmacokinetic studies using PET. J. Nucl. Biol. Med., 1994, 38, 96-98.
60. Young, H.; Carnochan, P.; Trivedi, M.; Potter, G. A.; Eccles, S. A.; Haynes, B. P.; Jarman, M.; Ott, R. J. Pharmacokinetics and biodistribution of radiolabelled idoxifene: prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapy. Nucl. Med. Biol., 1995, 22, 405-411.
61. 124I-labeled small molecular tracer and positron emission tomography. Mol. Imaging Biol., 2006, 8, 262-277. (Pubitemid 44446020)
62. Graf, F.; Mosch, B.; Koehler, L.; Bergmann, R.; Wuest, F.; Pietzsch, J. Cyclin-dependent kinase 4/6 (cdk4/6) inhibitors: perspectives in cancer therapy and imaging. Mini Rev. Med. Chem., 2010, 10, 527-539.
63. 131I]-2-(4-iodophenylamino) pyrido[2, 3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors. Nucl. Med. Biol., 2005, 32, 313-321. (Pubitemid 40692681)
64. 124I]IMPY, a thioflavin-S derivative, in transgenic mouse models of Alzheimer's disease. Appl. Radiat. Isot., 2009, 67, 1397-1400.
65. 124I]AM281 PET demonstrated in a schizophrenic patient. Psychiatry Res., 2006, 147, 249-256. (Pubitemid 44397467)
66. 124I-labeling of m-iodophenylpyrrolomorphinan as a potential PET imaging agent for delta opioid (DOP) receptors. J. Label. Compd. Radiopharm., 2007, 50, 165-170. (Pubitemid 46750662)
67. 124I- metaiodobenzylguanidine (MIBG) PET. Med. Phys., 2010, 37, 4861-4867.
68. Doubrovin, M.; Ponomarev, V.; Beresten, T.; Balatoni, J.; Bornmann, W.; Finn, R.; Humm, J.; Larson, S.; Sadelain, M.; Blasberg, R.; Gelovani Tjuvajev, J. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc. Natl. Acad. Sci. U. S. A., 2001, 98, 9300-9305. (Pubitemid 32743911)
69. 124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression. Eur. J. Nucl. Med., 2001, 28, 721-729.
70. Culbert, P. A.; Hunter, D. H. Polymer-supported radiopharmaceuticals-I- 123-Labeled and I-131-labeled N-isopropyl-4-iodoamphetamine. React. Polym., 1993, 19, 247-253.
71. Hunter, D. H.; Zhu, X. Z. Polymer-supported radiopharmaceuticals: I-131 MIBG and I-123 MIBG. J. Label. Compd. Radiopharm., 1999, 42, 653-661.
72. Janabi, M.; Chacko, A.-M.; Smith, M. P.; Hunter, D. H.; Kula, N. S.; Tarazi, F. I.; Baldessarini, R. J.; Babich, J. W. A combinatorial, solid phase approach for preparation of radiopharmaceuticals. Synthesis of iodobenzamides as s-Ligands. J. Nuc. Med., 2003, 44, 166.
73. Vaidyanathan, G.; Affleck, D. J.; Alston, K. L.; Zhao, X. G.; Hens, M.; Hunter, D. H.; Babich, J.; Zalutsky, M. R. A kit method for the high level synthesis of At-211 MABG. Bioorg. Med. Chem., 2007, 15, 3430-3436. (Pubitemid 46529264)
74. Zhu, X.; Blough, B. E.; Carroll, F. I. Synthesis and reactions of a novel chlorostannane resin: coupling with functionalized organozinc halides. Tet. Lett., 2000, 41, 9219-9222.
75. Gifford, A. N.; Kuschel, S.; Shea, C.; Fowler, J. S. Polymersupported organotin reagent for prosthetic group labeling of biological macromolecules with radioiodine. Bioconjug. Chem., 2011, 22, 406-412.
76. Donovan, A. C.; Valliant, J. F. Fluorous isocyanates: convenient synthons for the preparation of radioiodinated compounds in high effective specific activity. J. Org. Chem., 2009, 74, 8133-8138.
77. McIntee, J. W.; Sundararajan, C.; Donovan, A. C.; Kovacs, M. S.; Capretta, A.; Valliant, J. F. A convenient method for the preparation of fluorous tin derivatives for the fluorous labeling strategy. J. Org. Chem., 2008, 73, 8236-8243.
78. Leader, B.; Baca, Q. J.; Golan, D. E. Protein therapeutics: a summary and pharmacological classification. Nat. Rev. Drug Discov., 2008, 7, 21-39.
79. van Dongen, G. A.; Vosjan, M. J. Immuno-positron emission tomography: shedding light on clinical antibody therapy. Cancer Biother. Radiopharm., 2010, 25, 375-385.
80. McCabe, K. E.; Wu, A. M. Positive progress in immunoPET-not just a coincidence. Cancer Biother. Radiopharm., 2010, 25, 253-261.
81. Jayson, G. C.; Zweit, J.; Jackson, A.; Mulatero, C.; Julyan, P.; Ranson, M.; Broughton, L.; Wagstaff, J.; Hakannson, L.; Groenewegen, G.; Bailey, J.; Smith, N.; Hastings, D.; Lawrance, J.; Haroon, H.; Ward, T.; McGown, A. T.; Tang, M.; Levitt, D.; Marreaud, S.; Lehmann, F. F.; Herold, M.; Zwierzina, H. Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. J. Natl. Cancer. Inst., 2002, 94, 1484-1493. (Pubitemid 35251753)
82. 124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol., 2007, 8, 304-310. (Pubitemid 46464522)
83. 124I-cG250. J. Nucl. Med., 2011
84. Knight, L. C.; Krohn, K. A.; Harwig, J. F.; Welch, M. J. Sites of direct and indirect halogenation of proteins. J. Label. Compd. Radiopharm., 1977, 13, 219. (Pubitemid 8045045)
85. Krohn, K. A.; Knight, L. C.; Harwig, J. F.; Welch, M. J. Differences in the sites of iodination of proteins following four methods of radioiodination. Biochim. Biophys. Acta, Protein Struct., 1977, 490, 497-505. (Pubitemid 8028488)
86. 124I-labeled monoclonal antibodies. Gynecol. Oncol., 1993, 48, 61-67. (Pubitemid 23056187)
87. 124I]A14-iodoinsulin as a radiotracer for positron emission tomography. J. Label. Compd. Radiopharm., 2001, 44, 465-480. (Pubitemid 32587782)
88. Iozzo, P.; Osman, S.; Glaser, M.; Knickmeier, M.; Ferrannini, E.; Pike, V. W.; Camici, P. G.; Law, M. P. In vivo imaging of insulin receptors by PET: preclinical evaluation of iodine-125 and iodine-124 labelled human insulin. Nucl. Med. Biol., 2002, 29, 73-82. (Pubitemid 34088164)
89. 124I-CDR-grafted humanized A33 monoclonal antibody. J. Nucl. Med., 2001, 42, 764-769. (Pubitemid 32453466)
90. Larson, S. M.; Pentlow, K. S.; Volkow, N. D.; Wolf, A. P.; Finn, R. D.; Lambrecht, R. M.; Graham, M. C.; Di Resta, G.; Bendriem, B.; Daghighian, F.; Yeh, S. D. J.; Wang, G.-J.; Cheung, N.-K. V. PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. J. Nucl. Med., 1992, 33, 2020-2023.
91. 131I-L19-SIP radioimmunotherapy. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36, 1235-1244.
92. Reddy, S.; Shaller, C. C.; Doss, M.; Shchaveleva, I.; Marks, J. D.; Yu, J. Q.; Robinson, M. K. Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment. Clin. Cancer Res., 2010
93. H2 for TAG-72 antigendirected positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results. World J. Surg. Oncol., 2010, 8, 65.
94. Fortin, M. A.; Salnikov, A. V.; Nestor, M.; Heldin, N. E.; Rubin, K.; Lundqvist, H. Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studies. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34, 1376-1387. (Pubitemid 47312573)
95. Verel, I.; Visser, G. W.; Boerman, O. C.; van Eerd, J. E.; Finn, R.; Boellaard, R.; Vosjan, M. J.; Stigter-van Walsum, M.; Snow, G. B.; van Dongen, G. A. Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET. Cancer Biother. Radiopharm., 2003, 18, 655-661. (Pubitemid 37082386)
96. 131I-radioimmunotherapy. Eur. J. Nucl. Med. Mol. Imaging, 2004, 31, 1645-1652. (Pubitemid 40104611)
97. 124I anti-CEA monoclonal antibody in tumor-bearing mice. Cancer Biother. Radiopharm., 2008, 23, 399-409.
98. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice. J. Nucl. Med., 2003, 44, 1962-1969. (Pubitemid 40022142)
99. Bakir, M. A.; Eccles, S.; Babich, J. W.; Aftab, N.; Styles, J.; Dean, C. J.; Lambrecht, R. M.; Ott, R. J. c-erbB2 protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodies. J. Nucl. Med., 1992, 33, 2154-2160.
100. 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies. Cancer Res., 1989, 49, 2807-2813. (Pubitemid 19143420)
101. Zalutsky, M. R.; Garg, P. K.; Narula, A. S. Labeling monoclonal antibodies with halogen nuclides. Acta Radiol. Suppl., 1990, 374, 141-145.
102. Tolmachev, V.; Orlova, A.; Lundqvist, H. Approaches to improve cellular retention of radiohalogen labels delivered by internalising tumour-targeting proteins and peptides. Curr. Med. Chem., 2003, 10, 2447-2460. (Pubitemid 37236398)
103. Wilbur, D. S. Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjug. Chem., 1992, 3, 433-470.
104. 125I-containing acylating agent. Biochem. J., 1973, 133, 529-539.
105. Rudinger, J.; Ruegg, U. Appendix: Preparation of N-succinimidyl 3-(4-hydroxyphenyl) propionate. Biochem. J., 1973, 133, 538-539.
106. 124I-iodinated N-succinimidyl 3-hydroxyphenyl propionate labeling of human antibodies. Med. Sci. Res., 1988, 16, 737-738.
107. 124I]I-SHPP) and its use for labelling a VEGF antibody as a PET tracer. J. Label. Compd. Radiopharm., 2002, 45, 1077-1090. (Pubitemid 35387709)
108. 124I]iodinated-VG76e: A novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography. Cancer Res., 2002, 62, 5912-5919. (Pubitemid 35204754)
109. Robinson, M. K.; Doss, M.; Shaller, C.; Narayanan, D.; Marks, J. D.; Adler, L. P.; Gonzalez Trotter, D. E.; Adams, G. P. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody. Cancer Res., 2005, 65, 1471-1478. (Pubitemid 40270176)
110. *I]iodobenzoate: a radio-iodination agent for labeling internalizing proteins and peptides. Nat. Protoc., 2007, 2, 282-286. (Pubitemid 47044697)
111. Vaidyanathan, G.; Affleck, D. J.; Zalutsky, M. R. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate. Bioconjug. Chem., 1997, 8, 724-729. (Pubitemid 27416087)
112. Vaidyanathan, G.; Zalutsky, M. R. Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents. Bioconjug. Chem., 1990, 1, 269-273.
113. Vaidyanathan, G.; Zalutsky, M. R. Radioiodination of antibodies via N-succinimidyl 2, 4-dimethoxy-3-(trialkylstannyl) benzoates. Bioconjug. Chem., 1990, 1, 387-393.
114. 131I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs. Bioconjug. Chem., 2003, 14, 331-341. (Pubitemid 36348656)
115. Koziorowski, J.; Henssen, C.; Weinreich, R. A new convenient route to radioiodinated N-succinimidyl 3-and 4-iodobenzoate, two reagents for radioiodination of proteins. Appl. Radiat. Isot., 1998, 49, 955-959. (Pubitemid 28264221)
116. 124I-labeled affibody molecule and trastuzumab in a murine xenograft model. J. Nucl. Med., 2009, 50, 417-425.
117. Glaser, M.; Collingridge, D. R.; Aboagye, E. O.; Bouchier-Hayes, L.; Hutchinson, O. C.; Martin, S. J.; Price, P.; Brady, F.; Luthra, S. K. Iodine-124 labelled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography. Appl. Radiat. Isot., 2003, 58, 55-62. (Pubitemid 35453947)
118. Collingridge, D. R.; Glaser, M.; Osman, S.; Barthel, H.; Hutchinson, O. C.; Luthra, S. K.; Brady, F.; Bouchier-Hayes, L.; Martin, S. J.; Workman, P.; Price, P.; Aboagye, E. O. In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope. Br. J. Cancer, 2003, 89, 1327-1333. (Pubitemid 37363425)
119. *I]iodobenzoate: an agent for the indirect radioiodination of proteins. Nat. Protoc., 2006, 1, 707-713.
120. Janabi, M.; Chacko, A.-M.; Hunter, D. H.; Babich, J. W.; Smith, M. P. Polymer-supported radiopharmaceutical precursors: benzamides and N-succinimidyl benzoates. J. Label. Compd. Radiopharm., 2003, 46, S20.
121. Stein, R.; Govindan, S. V.; Mattes, M. J.; Chen, S.; Reed, L.; Newsome, G.; McBride, B. J.; Griffiths, G. L.; Hansen, H. J.; Goldenberg, D. M. Improved iodine radiolabels for monoclonal antibody therapy. Cancer Res., 2003, 63, 111-118. (Pubitemid 36070428)
122. 131I for use in radioimmunotherapy. J. Nucl. Med., 2005, 46, 153-159. (Pubitemid 43086010)
123. 124I-IMP-R4-labeled antibody ch806. J. Nucl. Med., 2010, 51, 967-972.
124. Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer, 2005, 5, 161-171. (Pubitemid 40314948)
125. Farokhzad, O. C.; Langer, R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv. Drug. Deliv. Rev., 2006, 58, 1456-1459. (Pubitemid 44820502)
126. Cheon, J.; Lee, J. H. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc. Chem. Res., 2008, 41, 1630-1640.
127. Park, J. C.; Yu, M. K.; An, G. I.; Park, S. I.; Oh, J.; Kim, H. J.; Kim, J. H.; Wang, E. K.; Hong, I. H.; Ha, Y. S.; Choi, T. H.; Jeong, K. S.; Chang, Y.; Welch, M. J.; Jon, S.; Yoo, J. Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging. Small, 2010, 6, 2863-2868.
128. Choi, J. S.; Park, J. C.; Nah, H.; Woo, S.; Oh, J.; Kim, K. M.; Cheon, G. J.; Chang, Y.; Yoo, J.; Cheon, J. A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. Angew. Chem. Int. Ed. Engl., 2008, 47, 6259-6262.
129. Kumar, R.; Roy, I.; Ohulchanskky, T. Y.; Vathy, L. A.; Bergey, E. J.; Sajjad, M.; Prasad, P. N. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano, 2010, 4, 699-708.
130. Mougin-Degraef, M.; Jestin, E.; Bruel, D.; Remaud-Le Saec, P.; Morandeau, L.; Faivre-Chauvet, A.; Barbet, J. High-activity radioiodine labeling of conventional and stealth liposomes. J. Liposome Res., 2006, 16, 91-102.
131. Chrastina, A.; Schnitzer, J. E. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int. J. Nanomedicine, 2010, 5, 653-659.
132. Robertson, R.; Germanos, M. S.; Li, C.; Mitchell, G. S.; Cherry, S. R.; Silva, M. D. Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys. Med. Biol., 2009, 54, N355-365.
133. Dothager, R. S.; Goiffon, R. J.; Jackson, E.; Harpstrite, S.; Piwnica-Worms, D. Cerenkov radiation energy transfer (CRET) imaging: a novel method for optical imaging of PET isotopes in biological systems. PLoS One, 2010, 5, e13300.
134. Ruggiero, A.; Holland, J. P.; Lewis, J. S.; Grimm, J. Cerenkov luminescence imaging of medical isotopes. J. Nucl. Med., 2010, 51, 1123-1130.
135. Advancing Nuclear Medicine Through Innovation. National Academies Press (US): Washington, DC, 2007.